| |
|
|
|
|
|
|
|
|
|
|
|
![]() |
|
||||||||||
|
|
|
|
|
|
|
|
|||||
| |
|
||||||||||
|
Corporate Info Contact Information Atlantis Components, Inc.
Atlantis in the News
• Dental Lab Products (May 2006)
CAD/CAM
Outsource Guide: Patient-specific • Practical Procedures and Aesthetic
Dentistry (May 2003)
" • General Dentistry (July/ August 2001) Permanent Healing Abutments Executive Summary Atlantis, a
eight-year old company in the fast-growing dental device market, has developed a revolutionary technology to manufacture customized dental components using advanced computer modeling and machining. Prior to this development, to get good-looking, functional results, dentists had to customize their products by hand to fit a patients specific oral geometry. Very little automation or modern manufacturing technology has been developed for dentistry, resulting in an industry populated by high-cost craftsmen, a wide variety of treatment modes and a non-standardized way of doing business. Atlantis uses its computer and imaging technology to produce the Atlantis Abutment, a major improvement for dentists tasked with replacing missing teeth with dental implants. To meet the large and growing market need for lower cost and better results, Atlantis customizes the abutment to a patient's oral geometry using a computer modeling system and a precision machining process. The abutment supports the visible portion of the artificial tooth (the crown) and is attached to the top of the implant fixture that a surgical specialist has previously installed in the jawbone. The Atlantis Abutment removes the uncertainty of hand-made abutments and the inventory of standard parts, allowing the dentist to complete an implant procedure with a more predictable result in four patient visits instead of the current seven to ten. The Atlantis Abutment allows the dentist to make more profit in less time and bring implants to a larger part of the population by reducing the implant procedure price. The current worldwide implant market is approximately three million implant procedures per year and growing at 15% to 20% per year. The market potential is 15 million tooth replacements per year worldwide - 98% of which are dentures and bridges. Implants will be the therapy of choice once the cost of and time for the entire procedure are significantly reduced through products like the high-margin Atlantis Abutment. The abutment is sold to restorative dentists and surgical specialists through both a direct sales force and partner laboratories and requires no special training or equipment to use. With early success, Atlantis will exploit its worldwide patented technology to other dental products of significance. Atlantis has received FDA 510(k) clearance, built a staff of
50 and launched the product in the US. The abutment has drawn considerable attention from the dental industry as breakthrough articles have recently appeared in major dental journals. Atlantis is a venture capital funded, early-stage company. The primary investors are American Bailey Ventures (Stamford, CT), Massachusetts Technology Development Corporation (Boston, MA) and VIMAC (Boston, MA). Investor relations packages are available through
Douglas Bailey, CEO. Management Team
Douglas G. Bailey, Chief Executive Officer
Mr. Bailey is
the founder and Managing Director of American Bailey Ventures (ABV).
ABV creates and manages venture capital investment opportunities
in early-stage businesses that are associated with leading
technological universities. Mr. Bailey is also co-founder and
chief executive of American Bailey Corporation (ABC), a private
equity firm. Mr. Bailey is a graduate of MIT with a Bachelor
of Science, Master of Science and an Engineer degree, all in
Mechanical Engineering. In 1978 he received his MBA degree from
Harvard Business School. Prior to founding ABC in 1984, Mr.
Bailey held a variety of manufacturing and marketing positions
at Corning Inc. beginning in 1978. From 1980 to 1988, he was a
founding director of VideoStar Connections, Inc., a successful
satellite communications start-up now known as Convergent Media
Systems Corporation. His directorships include Fuel-Tech N.V. (NASD:
FTEK), where he serves as Deputy Chairman, and Endocyte, Inc.,
an early-stage biotechnology company.
James G. Hannoosh, Ph.D., Senior Vice President – Business
Development Dr. Hannoosh
founded and was President of CERBEC, Inc., one of the world’s
first successful advanced ceramic materials companies. After
leaving CERBEC in 1992, Dr. Hannoosh has worked closely with
several venture capital firms and their portfolio companies.
Dr. Hannoosh has been a principal with American Bailey Ventures
since 1997 and has been an Atlantis director since May 2000.
Dr. Hannoosh led Atlantis as its CEO from September 2000 until
June 2003. His accomplishments included the development of a
comprehensive, cost effective manufacturing process including
Virtual Abutment Design, automated design, proprietary machining
and a non-exclusive, worldwide distribution agreement with
Centerpulse Dental. Dr. Hannoosh received a Bachelor of
Science in Mechanical Engineering from Worcester Polytechnic
Institute in 1970 and a Master of Science and Ph.D. in
Mechanical Engineering from MIT in 1972 and 1975, respectively.
Mr. Thomas J. Cole, President
Mr. Cole received his Bachelor of Science degree in Mechanical
Engineering from MIT in 1991 and subsequently joined General
Electric and completed its Manufacturing Management Program. In
his final position at GE, he directed the efforts of 100
machinists and several engineers and professionals. In 1996, he
left GE to found a high-technology company that developed a new
screen for laptop computers. Mr. Cole joined Atlantis in
January 1997 as its first employee.
Mr. Ronald S. Scharlack, Vice President – Technical Development
Mr. Scharlack came to Atlantis from Spire Corporation, where he
was General Manager of the Biomedical division. He has
extensive experience in the management of medical device product
lines and companies. Prior to joining Spire, he was the Manager
of Advanced Technology at Chiron Diagnostics. Mr. Scharlack
received his Bachelor of Science in Mechanical Engineering from
MIT and his Master of Science in Mechanical Engineering from
Stanford University, and he attended the PMD program at Harvard
Business School.
Mr. Michael F. Mancini, Vice President – Sales and Marketing
Mr. Mancini joined Atlantis in January 2004. He was formerly
Vice President- International and Vice President of Sales at
TissueLink Medical, and early stage medical device company, and
Vice President of Sales at Concentra Inc., a large managed heath
care company. He also held the position of Vice President of
Global Marketing for STERIS Corporation, one of the most
successful healthcare IPO’s in the 1990’s. Mr. Mancini has
substantial experience in sales and marketing management in the
health care sector, particularly in medical devices, patient
care systems and surgical products. Mr. Mancini received his
Bachelor of Arts in Communication Science from the University of
Connecticut and Masters in Business Economics from Southern
Connecticut State University.
Mr. Kevin M. Curtin, Controller
Mr. Curtin joined Atlantis in February 2004. He was formerly
corporate controller of Standard MEMS Inc., a manufacturer of
microelectromechanical computer chips, and of the Monitor Group,
an international strategy consulting firm. Mr. Curtin also held
financial management and internal audit positions in the U.S.
and Singapore with Augat Inc. / Thomas & Betts Corporation, one
of the world’s largest manufacturers of electrical connectors.
He is a Certified Public Accountant and has broad experience as
a controller and financial manager of businesses in the
manufacturing, consulting and high technology sectors. Mr.
Curtin received his Bachelor of Science in accounting from St.
Michael’s College. Board of Directors
The Company’s Board is composed of
seven directors: Robert C. Roeper (Chairman), Douglas G. Bailey
(CEO), James H. Black, Jr., Dr. Julian Osorio, Andreas Frank,
Robert G. Stockard and M. Joshua Tolkoff. Brief biographies of
the non-management directors are provided below.
Mr. Robert C. Roeper, Chairman Mr. Roeper is
the Managing Director of VIMAC Ventures LLC (VIMAC). Prior to
joining VIMAC in 1995, he was a founder, senior officer and
director of Occam Research, a venture-funded developer of
desktop data analysis software, from 1989 to 1994. >From 1975
to 1989 he held various senior positions in marketing and
management within several divisions of Colgate Palmolive and The
Kendall Company. During his career he has led and participated
in over 40 rounds of venture financing and has helped found and
manage several start-up organizations both in the United States
and Asia. Mr. Roeper holds an MBA from the Amos Tuck School at
Dartmouth College and currently sits on a number of corporate
boards.
Mr. James H. Black, Jr.
Mr. Black was
most recently Chairman and CEO of AvData Systems, Inc. until its
merger with ITC^DeltaCom, a public telecommunications provider
in 1999. Earlier, he co-founded VideoStar Connections, Inc.
which was acquired by EDS in 1989. Subsequent to VideoStar, Mr.
Black was a founding investor in several new enterprises,
including Show Solutions, which was acquired by a public company
in 1997. Prior to his entrepreneurial activities, he held
senior positions in sales and marketing for Scientific-Atlanta.
He is Chairman of Norelli & Company, a strategic management
consulting firm, and is an advisor to American Bailey Ventures.
He currently serves as a director of Learn.net, Inc., a learning
management company and Air Quality Sciences, Inc., an indoor
environmental testing and product certification business. Mr.
Black helped launch the MIT Enterprise Forum Chapter in Atlanta,
served as Chairman in 2003 and is now a member of the Global
Forum Board headquartered at MIT in Cambridge. He earned
Bachelor of Science and Master of Science degrees in Mechanical
Engineering at MIT and a MBA from Harvard.
Dr. Julian Osorio Dr. Osorio is
the founder of Atlantis and the original inventor of the
Atlantis technology. He received his DMD degree in 1979 from
Javeriana University and completed his post-graduate training in
Prosthodontics at Boston University in 1983, receiving a Master
of Science in Dentistry in 1984 from the same institution. Dr.
Osorio has been on the faculty of the Division of Graduate and
Post-Graduate Prosthodontics at Tufts University School of
Dental Medicine since 1984. Dr. Osorio gives numerous lectures
around the world and is an active member of the American College
of Prosthodontics, the Massachusetts Dental Society, the
American Dental Association and the American Academy of
Osseointegration. Mr.
Andreas Frank Mr. Frank is
Vice President – Business Development of Danaher Corporation,
with responsibility for mergers, acquisitions and
investment/partnership activities for Danaher’s Dental Group.
Before taking this position in October 2004, Mr. Frank was an
engagement manager in the Corporate Finance and Strategy
Practice at McKinsey & Company, Inc. in Washington, D.C. Mr.
Frank holds an MBA from the University of Texas at Austin, and a
Masters and Bachelor of Economics and Business Administration
from the Otto Beisheim Graduate School of Management in Koblenz,
Germany.
Mr.
Robert G. Stockard Mr. Stockard is
an entrepreneur with particular experience in the organization
and management of sales teams. Mr. Stockard owns and manages
Sales Consultants of Boston, Inc., which provides executive
search and contractual executive staffing services. Mr.
Stockard was a founder of Salience, Inc., which organized and
provided outsourced sales forces specializing in the
telecommunications, medical and financial services industries.
Earlier, Mr. Stockard held several positions in customer service
and general management at Eastern Airlines. Mr. Stockard
attended the University of Massachusetts – Boston and is an
active participant in TEC International, the largest leadership
development organization for chief executives.
Mr. M. Joshua Tolkoff Mr. Tolkoff has
been active in the research, development and manufacturing of
medical devices for over 25 years and founded ACT Medical, Inc.
in 1990. Merged into MedSource Technologies, Inc. in January
2001, ACT Medical develops and manufactures proprietary medical
devices such as catheters and less invasive surgery devices for
other medical device companies. In 1986, he founded Harbor
Medical Devices, Inc. and was previously Vice President of Medi-Tech,
Inc., a division of Boston Scientific. Currently he is a
general partner in Ironwood Equity Fund, a later-stage /
mezzanine venture capital fund affiliated with Ironwood
Capital. A graduate of Harvard and MIT, Mr. Tolkoff has 19
patents for medical devices. |
. . .more than just an abutment company.
|
|
|||||||||
| |
|||||||||||
| |
|||||||||||
| |
|
||||||||||